z-logo
open-access-imgOpen Access
Costs of Second Allogeneic Hematopoietic Cell Transplantation
Author(s) -
Nandita Khera,
Barry E. Storer,
Brenda M. Sandmaier,
Michael K. Chapko,
Stephanie J. Lee
Publication year - 2013
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e318294caf1
Subject(s) - medicine , transplantation , malignancy , hematopoietic cell , surgery , haematopoiesis , stem cell , biology , genetics
A second allogeneic transplantation after a prior allogeneic (allo-allo) or autologous (auto-allo) hematopoietic cell transplantation (HCT) is usually performed for graft failure, disease recurrence, secondary malignancy, and, as planned, auto-allo transplantation for some diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom